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Anaesthesia-related mortality is an important, potentially avoidable 
cause of perioperative mortality. The current worldwide anaesthesia-
related mortality rate has decreased in recent years to <1 death per 
10 000 anaesthetics.[1] Among the reasons for this drop are better 
monitoring techniques,[1-3] improved postoperative monitoring and 
care in the recovery room,[2] better training of anaesthesiologists[3,4] 
and the adoption of safety standards and practice guidelines.[1-3] 
These improvements can be attributed to the identification of 
problem areas by conducting mortality and morbidity audits.[5]
A procedure-related death notification (PRDN) instrument is 
completed by relevant medical practitioners after an anaesthetic-
related death and can be used to audit practice and identify areas 
of care that need improvement. It is also used in medicolegal 
investigations when establishing cause of death, and in the case of 
litigation. The current South African (SA) PRDN instrument, the 
GW7/24 form (Report of Person Whose Death is Associated with 
the Administration of an Anaesthetic or a Diagnostic or Therapeutic 
Procedure), originally published in the 1970s, is anecdotally 
considered to be outdated, inadequate and in need of revision.
Objectives
To develop and validate a new anaesthetic section of the SA PRDN 
instrument that can be used for any procedure-related death in the 
future, for epidemiological, forensic or academic purposes.[6] The 
revision of the surgical section of the SA PRDN instrument was not 
within the scope of this study.
Methods
Approval to conduct the study was obtained from the Human Research 
Ethics Committee (Medical) (ref. no. M160684) and the Postgraduate 
Committee of the University of the Witwatersrand, Johannesburg.
The study comprised a two-stage process of instrument 
development and validation using Lynn’s methodology, consisting of 
a development stage and a judgement-quantification stage.[7]
Development stage
The development stage comprised three steps: domain identification, 
item generation and instrument formation. An extensive literature 
review was performed (domain identification) and a provisional 
PRDN instrument was produced (item generation). The literature 
review focused on extracting factors that are considered to be 
important in anaesthesia- and procedure-related deaths. Both locally 
and internationally published anaesthesia morbidity and mortality 
audits and PRDN instruments were included in the literature search. 
These extracted factors were then included in the provisional PRDN 
instrument. The instrument formation step involved a review of the 
provisional PRDN instrument, which was debated in a peer group 
discussion consisting of 6 experts.
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Background. Anaesthesia-related mortality is an important, potentially avoidable cause of perioperative mortality. A procedure-related 
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Methods. Lynn’s two-stage model was utilised. After an extensive literature review, a provisional PRDN instrument was developed. This 
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instrument was developed, which was then rated by 8 national experts using a Likert scale. The content validity index (CVI) for each item 
and for the instrument as a whole was then established. Items with a CVI <0.88 were removed to formulate the final PRDN instrument.
Results. The provisional PRDN instrument consisted of 14 domains and 66 items. The revised PRDN instrument consisted of 13 domains 
and 65 items, of which 3 items with a CVI <0.88 were removed. The final PRDN instrument, after minor revisions based on suggestions 
from the 8 national experts, consisted of 18 domains and 79 items. Every item on the form was declared relevant and important by the 
national experts, with the final instrument scoring an overall CVI of 1.
Conclusions. A comprehensive, updated and validated anaesthetic section of the SA PRDN instrument was developed. This could be used 
as a government and anaesthesiology society-endorsed template when updating the current GW7/24 form.
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According to Lynn,[7] the number of experts who should be used 
in this stage often depends on the availability of accessible and 
agreeable experts, but a minimum of 5 would provide an adequate 
level of control to rule out chance agreement. The maximum number 
of experts has not been established, but is unlikely to be more than 
10. Six experts participated in the peer group discussion in this 
study: 4 anaesthesiologists and 2 forensic pathologists. The experts 
in each stage were chosen in consultation with senior anaesthetic 
and forensic pathology consultants. They were chosen based on 
their knowledge of procedure-related deaths and the medicolegal 
processes surrounding these deaths in SA and elsewhere. They 
consisted of anaesthesiologists and forensic pathologists working in 
SA who were willing to participate in the study. This group of experts 
were only used in the development stage and were not involved in the 
later judgement-quantification stage.
The provisional PRDN instrument and information sheet were 
sent to each participating expert in advance. All 6 invited experts 
participated in the discussion, which was chaired by the principal 
investigator and held at Charlotte Maxeke Johannesburg Academic 
Hospital, Johannesburg. The aim of the discussion was to refine the 
provisional PRDN instrument in order to improve its content validity. 
During the discussion, the experts were asked to grade each item 
according to the following Likert scale: 
1. Not important
2. Of little importance
3. Important but needs alteration
4. Important and succinct.
A score of 3 or 4 meant that the item was important and should 
remain on the form, and a score of 1 or 2 meant that it should be 
removed. Each item on the provisional PRDN instrument was 
debated until complete consensus was reached. The experts were also 
encouraged to make suggestions for the inclusion of additional items. 
After the peer group discussion, the provisional PRDN instrument 
was refined to produce a revised PRDN instrument to be used in the 
judgement-quantification stage. The revised instrument was emailed 
to the experts to confirm that the discussed changes had been made.
Judgement-quantification stage
The judgement-quantification stage involved two stages: validation 
by rating each item in the revised RPDN instrument, and calculating 
the content validity index (CVI) of each item and of the instrument 
as a whole.
The number of experts needed in this stage follows the same 
principles as in the development stage.[7] When 6 or more participants 
are used, one expert can be in disagreement with the others and the 
instrument will still be assessed as content valid; however, if there are 
5 or fewer participants, all the participants must agree. In this study, 
10 experts were invited to participate, of whom 8 responded. During 
this stage the revised PRDN instrument, along with an information 
sheet describing the study and giving instructions on how to rate the 
items, was emailed to each participating expert around SA. None of 
the experts who participated in the judgement-quantification stage 
was involved in the previous development stage.
The content validity of each item in the revised RPDN instrument 
was independently rated by each of the 8 experts according to the 
same Likert scale used in the development stage, as described by 
Lynn.[7] The CVI for each item is the proportion of experts who rated 
that item as content valid by giving it a score of 3 or 4 on the Likert 
scale. The proportion of experts who need to agree on each item in 
order for it to be real agreement v. chance was determined by setting 
the standard error of the proportion as 7 out of 8 experts agreeing 
(0.88). If fewer than 7 out of 8 of the experts scored the item with a 3 
or 4, the item was removed from the form. The CVI was then applied 
to the entire form by determining the proportion of total items 
judged as being content valid.[7,8]
Results
Development stage
The demographics of the 6 local experts present at the development 
stage peer group discussion and the 8 national experts who responded 
to the email in the judgement-quantification stage are shown in Table 1.
A provisional PRDN instrument was developed during the 
development stage through a thorough literature review of 11 journal 
articles[1,3,4,9-16] related to anaesthesia-related mortality and morbidity. 
The provisional PRDN instrument consisted of 14 domains, namely 
demographics, hospital, anaesthetist, preoperative assessment, 
anaesthetic technique, induction, airway (if applicable), ventilation, 
monitoring and equipment, drugs, fluids, preoperative care, cardiac 
arrest (if applicable), and cause of death. The 14 domains contained 
66 items in total. The provisional PRDN instrument is available as a 
supplementary file (http://www.samj.org.za/public/sup/14083-1.doc).
This provisional instrument was debated at the peer group 
discussion and a revised PRDN instrument was developed. A total 
of 13 items were added, 11 items were changed or revised, and 
8 items were omitted and replaced with 2 questions that were more 
comprehensive, all to provide more clarity. The revised PRDN 
instrument contained 13 domains with 65 items in total. The revised 
PRDN instrument is available as a supplementary file (http://www.
samj.org.za/public/sup/14083-2.doc).
Judgement-quantification stage
There were only 3 items that the 8 experts did not agree on, and these 
items were removed from the form. The CVI for the revised PRDN 
instrument as a whole was 0.96, making it content valid. Although the 
revised PRDN instrument achieved an adequate score to enable it to 
stand alone as a content-valid instrument, it was decided to improve 
this form even further. The national experts made several useful 
comments and suggestions that were taken into consideration and 
incorporated into the final PRDN instrument. Alterations included 
10 additions and 6 modifications, and the 3 items with a CVI <0.88 
were removed. The final PRDN instrument, which consisted of 18 
domains and 79 items, was then re-rated by the national experts and 
achieved a CVI of 1 (Table 2).
Table 1. Demographics of local experts and national experts who participated in the development and judgement-
quantification stages
Sex Specialty
Years of 
experience Province
Stage Male Female Anaesthetist
Forensic 
pathologist ≥10 <10 Gauteng
KwaZulu-
Natal
Western 
Cape
Development stage, n (%) 1 (17) 5 (83) 4 (67) 2 (33) 2 (33) 4 (67)  6 0 0
Judgement-quantification stage, n (%) 3 (38) 5 (63) 5 (63) 3 (38) 7 (88) 1 (13) 5 (63) 1 (13) 2 (25)
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Table 2. Final procedure-related death notification instrument
Item and domain
Demographics (to be repeated on every page)
1.1 Name of patient
1.2 Age
1.3 Sex
1.4 Hospital number
Hospital
2.1 Name of hospital
2.2 Level of hospital (PHC facility/district/regional/tertiary/other – please specify)
Anaesthetist
3.1 Level of training (intern/community service officer/medical officer (state with or without diploma in anaesthesia)/registrar/consultant)
3.2 Was there an assistant (doctor or nurse) present during induction? If yes, please specify who
3.3 Was there an assistant (doctor or nurse) present during emergence? If yes, please specify who
3.4 Was there a changeover of anaesthetist during the case?
Preoperative assessment
4.1 Elective or emergency surgery
4.2 History of presenting problem
4.3 Relevant comorbid diseases
4.4 Acute and chronic medication
4.5 Relevant previous anaesthetics
4.6 Allergies
4.7 Clinical examination
4.8 Results of relevant special investigations (e.g. CXR, ECG, blood results)
4.9 Final clinical assessment and ASA rating (include table of ASA scoring system for those not familiar with it)
4.10 Hours since last meal. Specify:
a) Solids and infant formula
b) Breastmilk
c) Clear fluids
4.11 Preoperative optimisation
4.12 Premedication prescribed
Anaesthetic technique
5.1 General (specify elective sequence or rapid-sequence induction)
5.2 Regional (specify which)
5.3 Combined general and regional (specify)
5.4 Conscious sedation
5.5 Other (specify)
Induction
6.1 Date and time of induction
6.2 Were there any problems during induction and how were they managed?
Airway (if applicable)
7.1 Type and size (e.g. endotracheal tube, supraglottic airway device, oropharyngeal, facemask oxygen)
7.2 Was there any difficulty with the airway and how was it managed?
Ventilation
8.1 Please state mode of ventilation (e.g. spontaneous, IPPV, assisted ventilation) 
8.2 Were there any problems with ventilation of the patient and how were they managed?
Regional anaesthesia (if applicable)
9.1 Were there any complications due to the regional technique and how were they managed?
Monitoring and equipment
Please tick which equipment was used during the procedure
10.1 Pulse oximetry
10.2 Capnography
10.3 ECG
10.4 Non-invasive blood pressure
10.5 Arterial line
10.6 Central venous catheter
10.7 Temperature probe
10.8 Urinary catheter
Continued ... 
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Discussion
A death due to anaesthesia is a tragic event for the patient, their family, 
and the medical practitioners involved. Although the anaesthesia-
related mortality rate in SA has decreased, there is still a lot that can 
be done to make anaesthesia safer. To identify which areas of practice 
need improving, and where resources need to be allocated, accurate 
audits of mortality and morbidity need to be carried out. To do this 
adequately, proper documentation describing the perioperative events 
is required. One such document is the anaesthetic chart, and another is 
the PRDN instrument that is completed in the event of a death.
A comprehensive PRDN instrument is also needed in medicolegal 
situations. Forensic pathologists need the information in order 
Table 2. (continued) Final procedure-related death notification instrument
Item and domain
10.9 Nerve stimulator
10.10 Nasogastric tube
10.11 Forced air warmer
10.12 Fluid warmer
10.13 Arterial blood gas
10.14 Gas analyser
10.15 Other
10.16 Were there any problems with equipment and monitoring?
IVI access
11.1 What IVI access was available during the case?
Drugs
Please state which drugs were used for (name, dose, route)
12.1 Induction 
12.2 Muscle relaxants
12.3 Analgesia
12.4 Maintenance
12.5 Emergence
12.6 Recovery room/PACU
12.7 Drugs used for regional anaesthesia
12.8 Please state any other drugs used during the procedure (name, dose, route)
12.9 Were there any adverse drug reactions and how were these managed?
Fluids 
13.1 Fluid input (type, amount, route)
13.2 Blood products (type, amount, route)
13.3 Were there any adverse fluid and blood product reactions?
13.4 Estimated blood loss (mL)
13.5 Estimated urine output (mL)
Postoperative care
14.1 Please state where patient went after surgery and in what condition they arrived at their destination (straight to ward, recovery room, high 
care, ICU, other)
14.2 Was ICU requested? If denied, please state reasons why
14.3 Were there any immediate postoperative complications?
15. Cardiac arrest (if present during the arrest)
15.1 Date and time of arrest
15.2 Please describe details of the arrest
15.3 Management of arrest, including drugs and doses
16. Details of death
16.1 Date and time of death
16.2 Exact place of death
16.3 In your opinion, what was the likely cause of death?
17. Other
17.1 Please add any other important information relevant to the case
18. Demographics of doctor
18.1 Doctor name
18.2 Qualifications
18.3 Contact details
18.4 Signature
PHC = primary healthcare; CXR = chest radiograph; ECG = electrocardiogram; ASA = American Society of Anesthesiologists; IPPV = intermittent positive-pressure ventilation;  
IVI = intravenous injection; PACU = post-anaesthesia care unit; ICU = intensive care unit.
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to establish the cause of death and to decide whether an inquest 
should be held. Medical practitioners use this form when defending 
themselves in the case of an inquest or formal prosecution. There are 
several differences between the anaesthetic sections of the current 
GW7/24 form and the final PRDN instrument developed by the 
present study.
Under the domain ‘Hospital’, an option was added to specify the 
level of hospital as primary healthcare facility, district, regional, 
tertiary or other. This information is important in SA, as there is a 
difference in anaesthesia-related mortality rates between different 
hospital levels. There is a need to collect accurate, region-specific 
anaesthetic information in order to identify where resources need to 
be allocated and how to strengthen anaesthetic services at primary, 
district and regional levels.[17]
The domain ‘Anaesthetist’ included a question asking for more 
detail on the experience level of the anaesthetist and whether there 
was assistance available to them. Community service officers in 
district and regional centres in SA, with little or no anaesthetic 
experience, are often expected to anaesthetise patients alone. Studies 
in both Australia and Scotland have shown that there is a link between 
inexperienced anaesthetists and anaesthesia-related mortality.[18-20] 
Illustrating this in SA would lead to better training and support of 
doctors working in rural areas, potentially improving care to rural 
populations.
The domain ‘Monitoring and equipment’ was an addition to 
the final PRDN instrument. It was suggested at the peer group 
discussion that a tick-box format would suit this domain and 
would be an efficient way of collecting important information that 
is not included in the current GW7/24 form. It has been shown in 
the literature that there is an association between the use of pulse 
oximetry and end-tidal carbon dioxide monitoring and a reduction 
in respiratory-related damaging events.[21] Although it is not easy 
to prove that specific monitors reduce mortality, it is important to 
observe their effect on patient outcome and other safety-related 
measures, especially as new monitoring techniques are continually 
being developed.[22]
Part C of the GW7/24 form, completed by the surgeon, asks for 
details about conditions such as shock and haemorrhage – how they 
affected the course of the procedure and how they were managed. It 
was considered by both local and national experts that the fluid and 
drug management of shock and haemorrhage during a procedure is 
usually the responsibility of the anaesthetist and should therefore be 
included in the anaesthetic part of a PRDN instrument. The domains 
‘IVI access’ and ‘Fluids’ were added and ask for specific details on 
fluid and blood management. Incorrect blood management has 
been particularly highlighted in the international literature as a 
cause of anaesthesia-related morbidity and mortality, with delayed 
blood transfusion causing hypotension, hypovolaemic shock and 
postoperative myocardial infarction in high-risk patients.[1,13]
Adequate monitoring and facilities during the postoperative period, 
including continued monitoring in the intensive care unit (ICU) for 
high-risk patients, have been shown to reduce perioperative mortality 
rates.[1,15,23] The Royal Australasian College of Surgeons Anaesthetic 
Case Form[24] includes detailed questions about recovery room 
management and a section on the use of intensive care and high-care 
unit resources. The GW7/24 form does not include any questions 
about the postoperative period, so it was decided that a postoperative 
care domain should be added to the final PRDN instrument, and 
that it should include a question about ICUs. In SA, ICU beds are 
scarce resources, resulting in many eligible patients being denied 
ICU services. The information obtained from question 4.2 in the 
final PRDN instrument, ‘Was ICU requested? If denied, please state 
reasons why’, may help to motivate for more ICU beds in the future.
The objective of this study was to develop and validate a revised 
anaesthetic section of the SA PRDN instrument. The final PRDN 
instrument produced in this study should be submitted to the South 
African Society of Anaesthesiologists (SASA) as a template for 
procedure-related mortality documentation. In collaboration with 
academic anaesthetic centres in SA, SASA can use this instrument as a 
society-endorsed document when lobbying the National Department 
of Health to update the current GW7/24 form.
Study limitations
This study is limited by the fact that the final PRDN instrument was 
not evaluated in a real-world setting. The new instrument should 
be piloted in a hospital or region to assess efficacy, usability and 
relevance. For example, a qualitative study could be performed to 
assess both anaesthetist and forensic pathology satisfaction with the 
instrument over a defined period of time.
In addition, only Part D of the GW7/24, relating to the anaesthesia, 
was revised in this study. Parts A, B and C of the form should also 
be updated in collaboration with surgical and forensic pathology 
colleagues.
Conclusions
The current SA PRDN form, the GW7/24, is outdated and inadequate, 
and needs to be revised. The final PRDN instrument developed 
in this study is comprehensive and validated and will adequately 
capture all the information required for epidemiological, forensic and 
academic purposes. This new instrument is a suitable replacement for 
Part D of the current GW7/24 form.
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